Literature DB >> 22732839

An alternative pathway in colorectal carcinogenesis based on the mismatch repair system and p53 expression in Korean patients with sporadic colorectal cancer.

Hyoung Ran Kim1, Hee Cheol Kim, Hae-Ran Yun, Seok Hyung Kim, Cheol Keun Park, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Ho-Kyung Chun.   

Abstract

PURPOSE: Microsatellite instability (MSI) and chromosomal instability are main mechanisms underlying colorectal carcinogenesis. We determined the features and prognosis of colorectal cancer based on MSI including mismatch repair genes and expression of p53.
METHODS: Between 1999 and 2008, a total of 2,649 colorectal cancer patients were analyzed using a prospective database. A mismatch repair defect (MMR-D) was defined as a loss of expression of more than one MMR protein and/or MSI-high. MMR-proficiency (MMR-P) was defined as expression of all MMR proteins and microsatellite stable (MSS)/MSI-low. Groups 1 (G1), 2 (G2), 3 (G3), and 4 (G4) were defined as MMR-D and p53-positive expression, MMR-D and p53-negative expression, MMR-P and p53-positive expression, MMR-P and p53-negative expression, respectively.
RESULTS: Eighty-two (3.0%), 181 (6.8%), 1,368 (51.7%), and 1,018 (38.5%) patients were classified into groups 1-4, respectively. Comparison between G1 and G2 showed differences in location (p < 0.001), size (p = 0.030), node metastasis (p = 0.027), distant metastasis (p = 0.009), and stage (p = 0.040). Comparison between G3 and G4 showed differences in location (p < 0.001) and histology (p < 0.001). Comparison between G1 and G3 showed differences in location (p < 0.001) and histology (p < 0.001). Comparison between G2 and G4 showed differences in age (p < 0.001), location (p < 0.001), size (p = 0.006), histology (p < 0.001), node metastasis (p < 0.001), distant metastasis (p < 0.001), and stage (p < 0.001). On multivariate analysis, stage (p = 0.007) and histology (p < 0.001) were associated with improved overall survival, and stage (p < 0.001) was associated with disease-free survival.
CONCLUSIONS: According to the MSI and p53 subsets, colorectal cancers showed different clinicopathologic features, but these subsets had no prognostic impact on overall and disease-free survival rate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22732839     DOI: 10.1245/s10434-012-2455-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

Review 1.  Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.

Authors:  Jung Ho Kim; Gyeong Hoon Kang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

2.  Do microsatellite instability (MSI) and deficient mismatch repair (dMMR) affect the pathologic complete response (pCR) in patients with rectal cancer who received neoadjuvant treatment?

Authors:  Turan Acar; Nihan Acar; Erdinç Kamer; Mustafa Agah Tekindal; Fevzi Cengiz; Haldun Kar; Kemal Atahan; Mehmet Haciyanli
Journal:  Updates Surg       Date:  2019-12-20

3.  [Clinicopathological features and types of microsatellite instability in 1394 patients with colorectal cancer].

Authors:  Xiangzhao Li; Huanjiao Liu; Minyi Liang; Huihui Chen; Li Liang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-11-30

4.  Immunohistochemical detection of p53 expression in patients with preoperative chemoradiation for rectal cancer: association with prognosis.

Authors:  Jung Wook Huh; Woo Yong Lee; Seok Hyung Kim; Yoon Ah Park; Yong Beom Cho; Seong Hyeon Yun; Hee Cheol Kim; Hee Chul Park; Doo Ho Choi; Joon Oh Park; Young Suk Park; Ho-Kyung Chun
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

5.  Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population.

Authors:  Wen-Yue Yan; Jing Hu; Li Xie; Lei Cheng; Mi Yang; Li Li; Jiong Shi; Bao-Rui Liu; Xiao-Ping Qian
Journal:  Onco Targets Ther       Date:  2016-12-08       Impact factor: 4.147

6.  The value of diffusion kurtosis imaging in assessing mismatch repair gene expression of rectal carcinoma: Preliminary findings.

Authors:  Qiang Feng; Hong Yu; Shihang Sun; Zhijun Ma
Journal:  PLoS One       Date:  2019-02-04       Impact factor: 3.240

7.  A case study of a long-term glioblastoma survivor with unmethylated MGMT and hypermutated genotype.

Authors:  Toni Rose Jue; Lauren R Olafson; Anna H Siddell; Robert W Rapkins; Benedict Ng; Julia X M Yin; Victor M Lu; Sylvia A Chung; Shane P Whittaker; Matthew Davies; Jacob M Fairhall; Elizabeth J Hovey; Kerrie L McDonald
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-06-03

8.  CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner.

Authors:  Xin Liu; Yunze Liu; Zhao Liu; Changwei Lin; Fanchao Meng; Lei Xu; Xiuzhong Zhang; Chong Zhang; Penbo Zhang; Shuai Gong; Nai Wu; Zeqiang Ren; Jun Song; Yi Zhang
Journal:  Mol Cancer       Date:  2021-09-08       Impact factor: 27.401

9.  Mismatch Repair Gene Expression as a Predictor of Tumor Responses in Patients With Rectal Cancer Treated With Preoperative Chemoradiation.

Authors:  Jung Wook Huh; Hee Cheol Kim; Seok Hyung Kim; Yoon Ah Park; Yong Beom Cho; Seong Hyeon Yun; Woo Yong Lee; Hee Chul Park; Doo Ho Choi; Joon Oh Park; Young Suk Park; Ho-Kyung Chun
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.